Although not proven in the present study, an intriguing hypothesis is that Meflin-mediated suppression of tissue fibrosis or decrease in interstitial pressure facilitates tumor vessel perfusion and therapeutic antibody delivery. This evidence concerns the gene ISLR and neoplasm.